Article Text

PDF
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates
  1. M Romano1,
  2. M R Iovene2,
  3. M I Russo1,
  4. A Rocco3,
  5. R Salerno1,
  6. D Cozzolino1,
  7. A P Pilloni2,
  8. M A Tufano2,
  9. D Vaira4,
  10. G Nardone3
  1. 1Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale, Gastroenterologia, Seconda Università di Napoli, Naples, Italy
  2. 2Microbiologia Clinica, Seconda Università di Napoli, Naples, Italy
  3. 3Dipartimento di Medicina Clinica e Sperimentale-Gastroenterologia, Università Federico II di Napoli, Naples, Italy
  4. 4Dipartimento di Medicina Interna e Gastroenterologia, Ospedale S. Orsola, Università of Bologna, Bologna, Italy
  1. Professor G Nardone, Dipartimento di Medicina Clinica e Sperimentale, Unità di Gastroenterologia, via Pansini 5, 80131 Naples, Italy; nardone{at}unina.it

Abstract

Objectives: Helicobacter pylori infection is a major health problem worldwide, and effective eradication of the infection is mandatory. The efficacy of recommended eradication regimens is approximately 70%. To avoid treatment failure and the consequent development of secondary resistance(s), it is important to choose the most appropriate first-line treatment regimen. This choice should also be made based on the knowledge of the antimicrobial resistance peculiar to a given geographical area. We evaluated the prevalence of antimicrobial-resistant H pylori strains isolated from naive patients and from patients with previous unsuccessful treatments.

Methods: This study examined 109 H pylori-infected subjects (Group 1) who had never received an eradication treatment and 104 H pylori-infected subjects (Group 2) who had failed one or more eradication treatments. Resistance to amoxicillin (AMO), tetracycline (TET), clarithromycin (CLA), metronidazole (MET) and levofloxacin (LEV) was determined using the epsilometer test. The significance of differences was evaluated by the χ2 test.

Results: The prevalence of antimicrobial resistance was 0% versus 3.1% to AMO, 0% versus 2% to TET, 27% versus 41.3% to MET (p<0.05), 18% versus 45.8% to CLA (p<0.05) and 3% versus 14.6% to LEV (p<0.05) in Group 1 vs Group 2, respectively. In Group 2, there was an increased prevalence of H pylori strains resistant to multiple antimicrobials.

Conclusions: This study confirms the high prevalence of H pylori strains resistant to CLA and MET, and indicates that unsuccessful treatments significantly increase resistance. Choosing eradication regimens other than standard triple therapy as a first-line therapy should be advisable in areas with high primary antimicrobial resistance prevalence.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethics approval: Ethics approval was provided by the Ethical Committee of the Second University and the Federico II University of Naples, Italy.

  • Patient consent: Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.